Bacterial Pathogens Associated with Hidradenitis Suppurativa, France
Hélène Guet-Revillet
, Hélène Coignard-Biehler, Jean-Philippe Jais, Gilles Quesne, Eric Frapy, Sylvain Poirée, Anne-Sophie Le Guern, Anne Le Flèche-Matéos, Alain Hovnanian, Paul-Henry Consigny, Olivier Lortholary, Xavier Nassif, Aude Nassif, and Olivier Join-Lambert
Author affiliations: Université Paris Descartes, Sorbonne Paris Cité, Paris, France (H. Guet-Revillet, J.-P. Jais, E. Frapy, A. Hovnanian, O. Lortholary, X. Nassif, O. Join-Lambert); Assistance-Publique Hôpitaux de Paris, Paris (H. Guet-Revillet, H. Coignard-Biehler, J-P. Jais, G. Quesne, S. Poirée, O. Lortholary, X. Nassif, O. Join-Lambert); Institut National de la Santé et de la Recherche U1151 eq11, Paris (H. Guet-Revillet, E. Frapy, X. Nassif, O. Join-Lambert); Institut National de la Santé et de la Recherche U872 eq22 (J-P. Jais); Institut National de la Santé et de la Recherche U 781, Paris (A. Hovnanian); Institut Pasteur, Paris (A. Le Flèche-Matéos, A-S. Le Guern, P.-H. Consigny, A. Nassif)
Main Article
Figure
Figure. Microbial diversity of hidradenitis suppurativa (HS) lesions as assessed by high-throughput 454 sequencing. The bacterial diversity of 6 consecutive and representative HS lesions was assessed by high-throughput sequencing. Sample 1 corresponded to an acute Staphylococcus lugdunensis abscess sampled by needle aspiration. Samples 2–3 (swabs) corresponded to Hurley stage 2 lesions of the axilla and inguinal folds, respectively. Samples 4–6 (swabs) corresponded to Hurley stage 3 lesions of the inguinal, axilla and gluteal fold, respectively. Staphylococcus spp. represented >99% of sequences of sample 1, whereas Prevotella spp. represented the most abundant taxon in 4/5 of these chronic suppurative lesions.
Main Article
Page created: November 18, 2014
Page updated: November 18, 2014
Page reviewed: November 18, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.